dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Moreno-García, E. |
dc.contributor.author | Puerta-Alcalde, P. |
dc.contributor.author | Gariup, G. |
dc.contributor.author | Fernández-Ruiz, M. |
dc.contributor.author | López Cortés, Luis |
dc.contributor.author | Cuervo, G. |
dc.contributor.author | Almirante Gragera, Benito |
dc.date.accessioned | 2022-01-13T13:31:02Z |
dc.date.available | 2022-01-13T13:31:02Z |
dc.date.issued | 2021-06 |
dc.identifier.citation | Moreno-García E, Puerta-Alcalde P, Gariup G, Fernández-Ruiz M, López Cortés LE, Cuervo G, et al. Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies. Open Forum Infect Dis. 2021 Jun;8(6):ofab250. |
dc.identifier.issn | 2328-8957 |
dc.identifier.uri | https://hdl.handle.net/11351/6784 |
dc.description | Antifúngic; Candidèmia; Desescalada |
dc.description.sponsorship | This research forms part of an activity that has received funding from EIT Health. EIT Health is supported by the European Institute of Innovation and Technology (EIT), a body of the European Union that receives support from the European Union´s Horizon 2020 Research and Innovation Program. This study has been cofunded by the European Regional Development Fund. E. M.-G. (PI18/01061), P. P.-A. (“Rio Hortega” contract CM18/00132), M. F.-R. (“Miguel Servet” contract CP18/00073), and C. G.-V. (FIS PI18/01061) have received research grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III. |
dc.language.iso | eng |
dc.publisher | Oxford University Press |
dc.relation.ispartofseries | Open Forum Infectious Diseases;8(6) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Medicaments antifúngics - Ús terapèutic |
dc.subject | Micosi - Tractament |
dc.subject | Càndida |
dc.subject.mesh | Candidemia |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Antifungal Agents |
dc.subject.mesh | /therapeutic use |
dc.title | Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1093/ofid/ofab250 |
dc.subject.decs | candidemia |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | antifúngicos |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://doi.org/10.1093/ofid/ofab250 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Moreno-García E, Puerta-Alcalde P, Gariup G] Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. [Fernández-Ruiz M] Hospital Universitario “12 de Octubre”, Instituto de Investigación Hospital “12 de Octubre” (imas+12), Universidad Complutense, Madrid, Spain. [López Cortés LE] Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, CSIC, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain. [Cuervo G] Hospital Universitari de Bellvitge, IDIBELL (Institut d’Investigació Biomèdica de Bellvitge), Universitat de Barcelona, Barcelona, Spain. [Almirante B] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 34104670 |
dc.identifier.wos | 000715364900045 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |